{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:58:47Z","timestamp":1787317127437,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Vestre Viken Hospital Trust"},{"name":"Ringerike Psychiatric Center"},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["223273"],"award-info":[{"award-number":["223273"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"KG Jebsen Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2009-4284"],"award-info":[{"award-number":["2009-4284"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2011-4787"],"award-info":[{"award-number":["2011-4787"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007709","name":"Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006019","name":"Van Andel Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.psyneuen.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T23:33:00Z","timestamp":1424820780000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers"],"prefix":"10.1016","volume":"56","author":[{"given":"Johan","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Verkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik Fredrik","family":"Malt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiv","family":"Sandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Ormstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2015.02.011_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0015","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism, relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14728222.2011.553603","article-title":"Pathobiological targets of depression","volume":"15","author":"Chopra","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0197-0186(95)00091-7","article-title":"The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits","volume":"28","author":"de Carvalho","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/PSY.0b013e318266d0f5","article-title":"Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the Young Finns Study","volume":"74","author":"Elovainio","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"l-Kynurenine: its synthesis and possible regulatory function in brain","volume":"5","author":"Gal","year":"1980","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-4347(95)00341-X","article-title":"Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection","volume":"675","author":"Herve","year":"1996","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"Pt. 2","key":"10.1016\/j.psyneuen.2015.02.011_bib0075","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert l-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0080","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0085","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","article-title":"Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation","volume":"26","author":"Hughes","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","article-title":"Cytokine imbalance in the pathophysiology of major depressive disorder","volume":"31","author":"Kim","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0095","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157339510791823835","article-title":"The concept of depression as a dysfunction of the immune system","volume":"6","author":"Leonard","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","article-title":"Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness","volume":"17","author":"Maes","year":"1993","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0115","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/ajp.156.7.1120","article-title":"Depression from interferon therapy in patients with hepatitis C","volume":"156","author":"Miyaoka","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2013.04.003","article-title":"Tryptophan metabolism and immunogenetics in major depression: a role for interferon-gamma gene","volume":"31","author":"Myint","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0140","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archpsyc.61.8.765","article-title":"Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls","volume":"61","author":"Neumeister","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0150","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12031-013-0097-2","article-title":"Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke","volume":"51","author":"Ormstad","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12031-014-0272-0","article-title":"Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke","volume":"54","author":"Ormstad","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.psyneuen.2014.03.013","article-title":"Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?","volume":"45","author":"Quak","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.1993.tb05836.x","article-title":"Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia","volume":"60","author":"Saito","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0180","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in Major Depressive Disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","article-title":"Indicators of immune activation in major depression","volume":"64","author":"Sluzewska","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2001-3401","article-title":"The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines","volume":"3","author":"Stone","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0205","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"25","author":"Sublette","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0021-9673(01)94149-4","article-title":"Automated sequential process for preparing samples for analysis by high-performance liquid chromatography","volume":"395","author":"Turnell","year":"1987","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0215","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0220","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D","article-title":"Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression","volume":"177","author":"Yuan","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.psyneuen.2015.02.011_bib0230","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645301500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645301500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:48:49Z","timestamp":1759682929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645301500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":46,"alternative-id":["S030645301500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.02.011","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}